Skip to main content Accessibility help
×
×
Home
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 2
  • Cited by
    This chapter has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Tondo, Leonardo and Baldessarini, Ross J. 2016. Suicidal Behavior in Mood Disorders: Response to Pharmacological Treatment. Current Psychiatry Reports, Vol. 18, Issue. 9,

    Baldessarini, Ross J. Tondo, Leonardo and Vázquez, Gustavo H. 2019. Pharmacological treatment of adult bipolar disorder. Molecular Psychiatry, Vol. 24, Issue. 2, p. 198.

    ×
  • Print publication year: 2014
  • Online publication date: October 2014

Section 4 - Treatment

Recommend this book

Email your librarian or administrator to recommend adding this book to your organisation's collection.

A Concise Guide to Understanding Suicide
  • Online ISBN: 9781139519502
  • Book DOI: https://doi.org/10.1017/CBO9781139519502
Please enter your name
Please enter a valid email address
Who would you like to send this to *
×

References

Ahearn, E. P., Chen, P., Hertzberg, M., et al. (2013). Suicide attempts in veterans with bipolar disorder during treatment with lithium, divalproex, and atypical antipsychotics. Journal of Affective Disorders, 145, 77–82.
Ahrens, B., & Müller-Oerlinghausen, B. (2001). Does lithium exert an independent antisuicidal effect?Pharmacopsychiatry, 34, 132–136.
American Psychiatric Association (APA). (2013) Diagnostic and Statistical Manual of Mental Disorders, fifth revision (DSM-5). Washington: American Psychiatric Publishing.
Angst, J., Angst, F., Gerber-Werder, R., et al. (2005). Suicide in 406 mood-disorder patients with and without long-term medication: 40–44 years follow-up. Archives of Suicide Research, 9, 279–300.
Baldessarini, R. J. (2013). Chemotherapy in Psychiatry, 3rd edn. New York: Springer Press.
Baldessarini, R. J., & Tondo, L. (2008). Lithium and suicidal risk. Bipolar Disorder, 10, 114–115.
Baldessarini, R. J., & Tondo, L. (2009). Suicidal risks during treatment of bipolar disorder patients with lithium versus anticonvulsants. Pharmacopsychiatry, 42, 72–75.
Baldessarini, R. J., Faedda, G. L., & Hennen, J. (2005). Risk of mania with serotonin reuptake inhibitors vs. tricyclic antidepressants in children, adolescents and young adults. Archives of Pediatric and Adolescent Medicine, 159, 298–299.
Baldessarini, R. J., Tondo, L., Davis, P., et al. (2006). Decreased suicidal risk during long-term lithium treatment: meta-analysis. Bipolar Disorder, 8, 625–639.
Baldessarini, R. J., Tondo, L., Strombom, I., et al. (2007). Analysis of ecological studies of relationships between antidepressant utilization and suicidal risk. Harvard Review of Psychiatry, 15, 133–145.
Baldessarini, R. J., Salvatore, P., Khalsa, H. M., et al. (2010). Morbidity in 303 first-episode bipolar I disorder patients. Bipolar Disorders, 12, 264–270.
Barbui, C., Esposito, E., & Cipriani, A. (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. CMAJ, 180, 291–297.
Barraclough, B. (1972). Suicide prevention, recurrent affective disorder and lithium. British Journal of Psychiatry, 121, 391–392.
Bauer, M., Forsthoff, A., Baethge, C., et al. (2003). Lithium augmentation therapy in refractory depression-update. European Archives of Psychiatry and Clinical Neuroscience, 253, 132–139.
Blüml, V., Regier, M. D., Hlavin, G., et al. (2013). Lithium in the public water supply and suicide mortality in Texas. Journal of Psychiatric Research, 47, 407–411.
Cipriani, A., Pretty, H., Hawton, K., et al. (2005). Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: systematic review of randomized trials. American Journal of Psychiatry, 162, 1805–1819.
Cipriani, A., Hawton, K., Stockton, S., & Geddes, J. R. (2013). Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis. BMJ, 346 (Epub ahead of print, 27 Jun).
Collins, J. C., & McFarland, B. H. (2008). Divalproex, lithium and suicide among Medicaid patients with bipolar disorder. Journal of Affective Disorders, 107, 23–28.
Coppen, A., & Farmer, R. (1998). Suicide mortality in patients on lithium maintenance therapy. Journal of Affective Disorder, 50, 261–267.
Coppen, A., Standish-Barry, H., Bailey, J., et al. (1991). Does lithium reduce mortality of recurrent mood disorders?Journal of Affective Disorders, 23, 1–7.
Dawson, E. B., Moore, T. D., & McGanity, W. J. (1972). Relationship of lithium metabolism to mental hospital admissions and homicide. Diseases of the Nervous System, 33, 546–556.
De Dios, C., Ezquiaga, E., Garcia, A., Soler, B., & Vieta, E. (2010). Journal of Affective Disorders, 125, 74–81.
Goodwin, F. K., Fireman, B., Simon, G. E., et al. (2003). Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA, 290, 1467–1473.
Guzzetta, F., Tondo, L., Centorrino, F., & Baldessarini, R. J. (2007). Lithium treatment reduces suicide risk in recurrent major depressive disorder. Journal of Clinical Psychiatry, 68, 380–383.
Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332–339.
Hennen, J., & Baldessarini, R. J. (2005). Reduced suicidal risk during treatment with clozapine: meta-analysis. Schizophrenia Research, 73, 139–145.
Hori, A. (1998). Pharmacotherapy for personality disorders. Psychiatry and Clinical Neurosciences, 52, 13–19.
Isometsä, E. T., Henriksson, M. M., Aro, H. M., et al. (1994). Suicide in major depression. American Journal of Psychiatry, 151, 530–536.
Jamison, K. R. (1986). Suicide and bipolar disorders. Annals of the New York Academy of Sciences, 487, 301–315.
Kapusta, N. D., Mossaheb, N., Etzersdorfer, E., et al. (2011). Lithium in drinking water and suicide mortality. British Journal of Psychiatry, 198, 346–350.
Kay, D. W. K., & Petterson, U. (1977) Manic-depressive illness. Acta Psychiatrica Scandinavica (Suppl), 269, 55–60.
Kessing, L. V., Søndergard, L., Kvist, K., et al. (2005). Suicide risk in patients treated with lithium. Archives of General Psychiatry, 62, 860–866.
Kessler, R. C., Berglund, P., Borges, G., et al. (2005). Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990–1992 to 2001–2003. JAMA, 293, 2487–2495.
Khan, A., Khan, S. R., Hobus, J., et al. (2011). Differential pattern of response in mood symptoms and suicide risk measures in severely ill depressed patients assigned to citalopram with placebo or citalopram combined with lithium: role of lithium levels. Journal of Psychiatric Research, 45, 1489–1496.
Koek, R. J., Yerevanian, B. I., & Mintz, J. (2012). Subtypes of antipsychotics and suicidal behavior in bipolar disorder. Journal of Affective Disorders, 143, 27–33.
Koukopoulos, A., & Koukopoulos, A. (1999). Agitated depression as a mixed state and the problem of melancholia. Psychiatric Clinics of North America, 22, 547–564.
Kovacsics, C. E., Gottesman, I. I., & Gould, T. D. (2009). Lithium’s antisuicidal efficacy: elucidation of neurobiological targets using endophenotype strategies. Annual Review of Pharmacology and Toxicology, 49, 175–198.
Kutcher, S. P., Amrton, P., & Korenblum, M. (1990). Adolescent bipolar illness and personality disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 29, 355–358.
Lauterbach, E., Felber, W., Müller-Oerlinghausen, B., et al. (2008) Adjunctive lithium treatment in the prevention of suicidal behaviour in depressive disorders: a randomised, placebo-controlled, 1-year trial. Acta Psychiatrica Scandinavica, 118, 469–479.
Lenz, G., Ahrens, B., & Denk, E. (1994). Mortalität nach Ausschneiden aus der Lithiumambulanz. In B. Müller-Oerlinghausen & A. Berghöfer (Eds.) Ziele und Ergebnisse der medicamentösen Prophylaxe affecktiver Psychosen (pp. 49–52). Stuttgart: G. Theme Verlag.
Lepkifker, E., Horesh, N., & Floru, S. (1985). Long-term lithium prophylaxis in recurrent unipolar depression. Acta Psychiatrica Belgica, 85, 434–443.
Lewitzka, U., Bauer, M., Felber, W., et al. (2013). Anti-suicidal effect of lithium: current state of research and its clinical implications for the long-term treatment of affective disorders. Nervenärzt, 84, 294–306.
Maes, M., Scharpé, S., Verkerk, R., et al. (1995). Seasonal variation in plasma L-Tryptophan availability in healthy volunteers: relationships to violent suicide occurrence. Archives of General Psychiatry, 52, 937–946.
Maj, M., Pirozzi, R., Magliano, L., et al. (2006). Agitated “unipolar” major depression: prevalence, phenomenology, and outcome. Journal of Clinical Psychiatry, 67, 712–719.
Malhi, G. S., Tanious, M., Das, P., Coulston, C. M., & Berk, M. (2013). Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs, 27, 135–153.
Manchia, M., Hajek, T., O’Donovan, C., et al. (2013). Genetic risk of suicidal behavior in bipolar spectrum disorder: analysis of 737 pedigrees. Bipolar Disorder (Epub ahead of print, 5 Jun)].
Mann, J. J., Stanley, M., McBride, P. A., & McEwen, B. S. (1986). Increased serotonin-2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. Archives of General Psychiatry, 43, 954–959.
Meltzer, H. Y., Alphs, L., Green, A. I., et al. International Suicide Prevention Trial Study Group. (2003). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60, 82–91.
Moberg, T., Nordström, P., Forslund, K., et al. (2011). CSF 5-HIAA and exposure to and expression of interpersonal violence in suicide attempters. Journal of Affective Disorders, 132, 173–178.
Müller-Oerlinghausen, B. (1985). Lithium long-term treatment: does it act via serotonin?Pharmacopsychiatry, 18, 214–217.
Müller-Oerlinghausen, B., & Lewitzka, U. (2010) Lithium reduces pathological aggression and suicidality: a mini-review. Neuropsychobiology, 62, 43–49.
Müller-Oerlinghausen, B., Müser-Causemann, B., & Volk, J. (1992). Suicides and parasuicides in a high-risk patient group on and off lithium long-term medication. Journal of Affective Disorders, 25, 261–270.
Müller-Oerlinghausen, B., Ahrens, B., & Felber, W. (2006). The suicide-preventive and mortality-reducing effect of lithium. In M. Bauer, P. Grof, & B. Müller-Oerlinghausen (Eds.) Lithium in Neuropsychiatry (pp. 179–192). London: Informa Healthcare.
Nilsson, A. (1999). Lithium therapy and suicide risk. Journal of Clinical Psychiatry, 60 (Suppl 2), 85–88.
Novick, D. M., Swartz, H. A., & Frank, E. (2010). Suicide attempts in bipolar I and bipolar II disorder: review and meta-analysis of the evidence. Bipolar Disorder, 12, 1–9.
Ohgami, H., Terao, T., Shiotsuki, I., et al. (2009). Lithium levels in drinking water and risk of suicide. British Journal of Psychiatry, 194, 464–465.
Oquendo, M. A., Galfalvy, H. C., Currier, D., et al. (2011). Treatment of suicide attempters with bipolar disorder: a randomized clinical trial comparing lithium and valproate in the prevention of suicidal behavior. American Journal of Psychiatry, 168, 1050–1056.
Pacchiarotti, I., Bond, D. J., Baldessarini, R. J., et al. (2013). International Society for Bipolar Disorders (ISBD) Task-Force report on antidepressant use in bipolar disorders. American Journal of Psychiatry, 170(11), 1249–1262.
Pandey, G. N., Pandey, S. C., Ren, X., et al. (2003). Serotonin receptors in platelets of bipolar and schizoaffective patients: effect of lithium treatment. Psychopharmacology, 170, 115–123.
Poole, A. J., James, H. D., & Hughes, W. C. (1978). Treatment experiences in the lithium clinic at St Thomas’ Hospital. Journal of the Royal Society of Medicine, 71, 890–894.
Price, L. H., Charney, D. S., Delgado, P. L., et al. (1990). Lithium and serotonin function: implications for the serotonin hypothesis of depression. Psychopharmacology, 100, 3–12.
Prien, R. F., Klett, C. J., & Caffey, C. M. (1974). Lithium prophylaxis in recurrent affective illness. American Journal of Psychiatry, 131, 198–203.
Rothenhäusler, H. B., & Kapfhammer, H. P. (1999). Outcome in borderline disorders: literature review. Fortschritte der Neurologie·Psychiatrie, 67, 200–217.
Saunders, K. E., & Hawton, K. (2009). Role of psychopharmacology in suicide prevention. Epidemiologia e Psichiatria Sociale, 18, 172–178.
Savitz, J., Lucki, I., & Drevets, W. C. (2009). 5-HT(1A) receptor function in major depressive disorder. Progress in Neurobiology, 88, 17–31.
Schrauzer, G. N., & Shrestha, K. P. (1990). Lithium in drinking water and the incidences of crimes, suicides, and arrests related to drug addictions. Biological Trace Element Research, 25, 105–113.
Simon, R. I., & Hales, R. E. (2012). Textbook of Suicide Assessment and Management, 2nd edn. Washington, DC: American Psychiatric Press.
Smith, E. G., Søndergård, L., Lopez, A. G., et al. (2009). Association between consistent purchase of anticonvulsants or lithium and suicide risk: longitudinal cohort study from Denmark, 1995–2001. Journal of Affective Disorders, 117, 162–167.
Swann, A. C., Lafer, B., Perugi, G., et al. (2013). Bipolar mixed states: an International Society for Bipolar Disorders task force report of symptom structure, course of illness, and diagnosis. American Journal of Psychiatry, 170, 31–42.
Teicher, M. H., Glod, C. A., & Cole, J. O. (1993). Antidepressant drugs and the emergence of suicidal tendencies. Drug Safety, 8, 186–212.
Tharoor, H., Kotambail, A., Jain, S., et al. (2013). Study of the association of serotonin transporter triallelic 5-HTTLPR and STin2 VNTR polymorphisms with lithium prophylaxis response in bipolar disorder. Psychiatric Genetics, 23, 77–81.
Thies-Flechtner, K., Müller-Oerlinghausen, B., Seibert, W., et al. (1996). Effect of prophylactic treatment on suicide risk in patients with major affective disorders: data from a randomized prospective trial. Pharmacopsychiatry, 29, 103–107.
Tondo, L., & Baldessarini, R. J. (2007). Suicidal risks among 2826 Sardinian major affective disorder patients. Acta Psychiatrica Scandinavica, 116, 419–428.
Tondo, L., Baldessarini, R. J., Hennen, J., et al. (1998). Lithium treatment and risk of suicidal behavior in bipolar disorder patients. Journal of Clinical Psychiatry, 59, 405–414.
Tondo, L., Hennen, J., & Baldessarini, R. J. (2001). Reduced suicide risk with long-term lithium treatment in major affective illness: A meta-analysis. Acta Psychiatrica Scandinavica, 104, 163–172.
Tondo, L., Isacsson, G., & Baldessarini, R. J. (2003). Suicide in bipolar disorder: risk and prevention. CNS Drugs, 17, 491–511.
Tondo, L., Albert, M. J., & Baldessarini, R. J. (2006). Suicide rates in relation to health-care access in the United States: an ecological study. Journal of Clinical Psychiatry, 67, 517–523.
Tondo, L., Vázquez, G. H., & Baldessarini, R. J. (2010). Mania associated with antidepressant-treatment: comprehensive meta-analytic review. Acta Psychiatrica Scandinavica, 121, 404–414.
Tondo, L.VisioliC, Baldessarini, R. J. (2013). Long-term morbidity in clinically treated bipolar I disorder patients in a Sardinian mood disorder center. Previously unpublished observations.
Vázquez, G. H., TondoL., & Undurraga, J., et al. (2013). Overview of antidepressant treatment in bipolar depression: critical commentary. International Journal of Neuropsychopharmacology, 22, 1–13.
Vergunst, F. K., Fekadu, A., Wooderson, S. C., et al. (2013). Longitudinal course of symptom severity and fluctuation in patients with treatment-resistant unipolar and bipolar depression. Psychiatry Research, 207(3), 143–149.
Waddington, D., & McKensie, I. P. (1994). Overdose rates in lithium-treated vs. antidepressant-treated outpatients. Acta Psychiatrica Scandinavica, 90, 50–52.
Wasserman, D., Rihmer, Z., Rujescu, D., et al. (2012). European Psychiatric Association (EPA) guidance on suicide treatment and prevention. European Journal of Psychiatry, 27, 129–141.
Watson, W. A., Litovitz, T. L., Klein-Schwartz, W., et al. (2004). Annual report of the American Association of Poison Control Centers toxic exposure surveillance system. American Journal of Emergency Medicine, 22, 335–404.
Yatham, L. N., Kennedy, S. H., Parikh, S. V., et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update for the management of patients with bipolar disorder. Bipolar Disorder, 15, 1–44.
Yerevanian, B. I., Koek, R. J., & Mintz, J. (2003). Lithium, anticonvulsants and suicidal behavior in bipolar disorder. Journal of Affective Disorders, 73, 223–228.

References

Altamura, C., Bobo, W. V., & Meltzer, H. Y. (2007). Factors affecting outcome in schizophrenia and their relevance for psychopharmacological treatment. International Clinical Psychopharmacology, 22, 249–267.
Axelsson, R., & Lagerkvist-Briggs, M. (1992). Factors predicting suicide in psychotic patients. European Archives of Psychiatry and Clinical Neuroscience, 241, 259–266.
Beasley, C. M. Jr, Tollefson, G. D., & Tran, P. V. (1997). Efficacy of olanzapine: an overview of pivotal clinical trials. Journal of Clinical Psychiatry, 58(Suppl 10), 7–12.
Bleuler, M. (1976). An approach to a survey of research results on schizophrenia. Schizophrenia Bulletin, 2, 356–357.
Bushe, C. J., Taylor, M., & Haukka, J. (2010). Mortality in schizophrenia: a measurable clinical endpoint. Journal of Psychopharmacology, 24(4 Suppl), 17–25.
Caldwell, C. B., & Gottesman, I. I. (1990). Schizophrenics kill themselves too: a review of risk factors for suicide. Schizophrenia Bulletin, 16, 571–589.
Cormac, I., Brown, A., Creasey, S., Ferriter, M., & Huckstep, B. (2010).A retrospective evaluation of the impact of total smoking cessation on psychiatric inpatients taking clozapine. Acta Psychiatrica Scandinavica, 121(5), 393–397.
De Hert, M., Correll, C. U., & Cohen, D. (2010). Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study. Schizophrenia Research, 117(1), 68–74.
Hall, R. L., Smith, A. G., & Edwards, J. G. (2003). Haematological safety of antipsychotic drugs. Expert Opinion on Drug Safety, 2, 395–399.
Hennen, J., & Baldessarini, R. J. (2005). Suicidal risk during treatment with clozapine: a meta-analysis. Schizophrenia Research, 73(2–3), 139–145.
Hoang, U., Goldacre, M. J., & Stewart, R. (2013). Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatrica Scandinavica, 127(3), 195–201.
Horvitz-Lennon, M., Donohue, J. M., Domino, M. E., & Norman, S -L. T. (2009). Improving quality and diffusing best practices: The case of schizophrenia. Health Affairs, 28(3), 701–712.
Kane, J., Honigfeld, G., Singer, J., & Meltzer, H. (1988). Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45(9), 789–796.
Knittel, D., Munn, G., & Simmer, E. (2008). Prodromal psychosis as an etiology of suicide: a case report and review of the literature. American Journal of Forensic Medicine and Pathology, 29(3), 238–241.
Leadbetter, R., Shutty, M., Pavalonis, D., et al. (1992). Clozapine-induced weight gain: prevalence and clinical relevance. American Journal of Psychiatry, 149(1), 68–72.
Masoudzadeh, A., & Khalilian, A. R. (2007). Comparative study of clozapine, electroshock and the combination of ECT with clozapine in treatment-resistant schizophrenic patients. Pakistani Journal of Biological Sciences, 10(23), 4287–4290.
Meltzer, H. Y. (2005). Suicide in schizophrenia, clozapine, and adoption of evidence-based medicine. Journal of Clinical Psychiatry, 66(4), 530–533.
Meltzer, H. Y. (2012). Clozapine: balancing safety with superior antipsychotic efficacy. Clinical Schizophrenia and Related Psychoses, 6(3), 134–144.
Meltzer, H. Y., & Okayli, G. (1995). Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. American Journal of Psychiatry, 152, 183–190.
Meltzer, H. Y., Alphs, L., Green, A. I., et al., for the International Suicide Prevention Trial Study Group. (2003a). Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Archives of General Psychiatry, 60, 82–89.
Meltzer, H. Y., Perry, E., & Jayathilake, K. (2003b). Clozapine-induced weight gain predicts improvement in psychopathology. Schizophrenia Research, 59, 19–27.
Merrill, D. B., Dec, G. W., & Goff, D. C. (2005). Adverse cardiac effects associated with clozapine. Journal of Clinical Psychopharmacology, 25(1), 32–41.
Modestin, J., Dal Pian, D., & Agarwalla, P. (2005). Clozapine diminishes suicidal behavior: a retrospective evaluation of clincial records. Journal of Clinical Psychiatry, 66, 534–538.
Muller-Siecheneder, F., Muller, M. J., Hillert, A., et al. (1998). Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome. Journal of Clinical Psychopharmacology, 18, 111–120.
Munro, J., O’Sullivan, D., Andrews, C., et al. (1999). Active monitoring of 12,760 clozapine recipients in the UK and Ireland. Beyond pharmacovigilance. The British Journal of Psychiatry, 175, 576–580.
Palmer, D. D., Henter, I. D., & Wyatt, R. J. (1999). Do antipsychotic medications decrease the risk of suicide in patients with schizophrenia?Journal of Clinical Psychiatry 60(Suppl 2): 100–103.
Palmer, B. A., Pankrantz, V. S., & Bostwick, J. M. (2005). The lifetime risk of suicide in schizophrenia. Archives of General Psychiatry, 62, 247–253.
Pompili, M., Lester, D., Dominici, G., et al. (2013). Indications for electroconvulsive treatment in schizophrenia: A systematic review. Schizophrenia Research, 146, 1–9.
Reid, W. H., Mason, M., & Hogan, T. (1998). Suicide prevention effects associated with clozapine therapy in schizophrenia and schizoaffective disorder. Psychiatric Services, 49, 1029–1033.
Siris, S. G., Bermanzohn, P. C., Mason, E. D., & Shuwall, M. D. (1994). Maintenance imipramine therapy for secondary depression in schizophrenia. A controlled trial. Archives of General Psychiatry, 51(2), 109–115.
Spivak, B., Roitman, S., Vered, Y., et al. (1998). Diminished suicidal and aggressive behavior, high plasma norepinephrine levels, and serum triglyceride levels in chronic neuroleptic-resistant schizophrenic patients maintained on clozapine. Clinical Neuropharmacology, 21, 245–250.
Thomas, S. H., Drici, M. D., Hall, G. C., et al. (2010). Safety of sertindole versus risperidone in schizophrenia: principal results of the sertindole cohort prospective study (SCoP). Acta Psychiatrica Scandinavica, 122(5), 345–355.
Tiihonen, J., Lönnqvist, J., Wahlbeck, K., et al. (2009). 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet, 374(9690), 620–627.
Tiwari, A. K., Need, A. C., Lohoff, F. W., et al. (2013). Exome sequence analysis of Finnish patients with clozapine-induced agranulocytosis. Molecular Psychiatry. 2013 Jun 11. doi: 10.1038/mp. 2013.74. [Epub ahead of print].
Tran, P. V., Hamilton, S. H., Kuntz, A. J., et al. (1997). Double-blind comparison of olanzapine versus risperidone in the treatment of schizophrenia and other psychotic disorders. Journal of Clinical Psychopharmacology, 17, 407–418.
Urichuk, L., Prior, T. I., Dursun, S., & Baker, G. (2008). Metabolism of atypical antipsychotics: involvement of cytochrome p450 enzymes and relevance for drug-drug interactions. Current Drug Metabolism, 9(5), 410–418.
Walker, A. M., Lanza, L. L., Arellano, F., & Rothman, K. J. (1997). Mortality in current and former users of clozapine. Epidemiology, 8, 671–677.
Warner, B., & Hoffmann, P. (2002). Investigation of the potential of clozapine to cause torsade de pointes. Adverse Drug Reactions Toxicology Review, 21(4),189–203.
Weiner, E., Conley, R. R., Ball, M. P., et al. (2010). Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine. Neuropsychopharmacology, 35(11), 2274–2283.
Yağcioğlu, A. E. A., Akdede, B. B. K., Turgut, T. I., et al. (2005). A double-blind controlled study adjunctive treatment with risperidone in schizophrenic patients partially responsive to clozapine: efficacy and safety. Journal of Clinical Psychiatry, 66, 63–72.
Zhu, B., Ascher-Svanum, H., Faries, D. E., et al. (2008). Costs of treating patients with schizophrenia who have illness-related crisis events. BMC Psychiatry, 8, 72.

References

Acharya, N., Rosen, A., Polzer, J., et al (2006). Duloxetine: Meta-analysis of suicidal behaviors and ideation in clinical trials for major depressive disorder. Journal of Clinical Psychopharmacology, 26, 587–594.
Beasley, C., Dornseif, B., Bosomworth, J., et al (1991). Fluoxetine and suicide: a meta-analysis of controlled trials of treatment for depression. BMJ, 303, 685–692.
Borys, D. J., Setzer, S. C., Ling, L. J., et al. (1992). Acute fluoxetine overdose: a report of 234 cases. American Journal of Emergency Medicine, 10, 115–120.
Bridge, J. A., Iyengar, S., Salary, C. B., et al. (2007). Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA, 297, 1683–1696.
Buckley, N. A., & McManus, P. R. (2002). Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data. BMJ, 325, 1332–1333.
Carpenter, D. J., Fong, R., Kraus, J. E., et al (2011). Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a completed set of randomized, placebo-controlled trials. Journal of Clinical Psychiatry, 72(11), 1503–1514.
Centers for Disease Control and Prevention. (2007). Suicide trends among youths and young adults aged 10–24 – United States, 1990–2004. Morbidity and Mortality Weekly Report, 56, 905–908
Emslie, G. J., Findling, R. L., & Yeung, P. P. (2007). Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials. Journal of the American Academy of Child and Adolescent Psychiatry, 46, 479–488.
Friedman, R., & Leon, A. (2007). Expanding the black box: depression, antidepressants, and the risk of suicide. New England Journal of Medicine, 356(23), 2343–2346.
Gibbons, R., Hur, K., Bhaumik, D. K., et al. (2005). The relationship between antidepressant medication use and rate of suicide. Archives of General Psychiatry, 62, 165–172.
Gibbons, R., Brown, C. H., Hur, K., et al. (2007a). Relationship between antidepressants and suicide attempts: an analysis of the veterans’ health administration data sets. American Journal of Psychiatry, 164, 1044–1049.
Gibbons, R. D., Brown, C. H., Hur, K., et al. (2007b). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry, 164(9), 1356–1363.
Gibbons, R. D., Brown, C. H., Hur, K., et al. (2012). Suicidal thoughts and behaviors with antidepressant treatment: reanalysis of the randomized placebo-controlled studies of fluoxetine and venlafaxine. Archives of General Psychiatry, 69(6), 580–587.
Grunebaum, M., Ellis, S., Duan, N., et al. (2012). Pilot randomized clinical trial of an SSRI vs Bupropion: Effects on suicidal behavior, ideation and mood in major depression. Neuropsychopharmacology, 37, 697–706.
Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332–339.
Hawton, K., Bergen, H., Simkin, S., et al. (2010). Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose. British Journal of Psychiatry, 196, 354–358.
Jenner, P. N. (1992). Paroxetine: an overview of dosage, tolerability and safety. International Clinical Psychopharmacology, 6(4), 69–80.
Kasper, S., Fuger, J., & Moller, J. H. (1992). Comparative efficacy of antidepressants. Drugs, 43, 11–23.
Kasper, S., Montgomery, S. A., Möller, H. J., et al. (2010). Longitudinal analysis of the suicidal behavior risk in short-term, placebo-controlled studies of mirtazapine in major depressive disorder. World Journal of Biological Psychiatry, 11(1), 36–44.
Khan, A., Khan, S., Kolts, R., et al. (2003). Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: analysis of FDA reports. American Journal of Psychiatry, 160, 790–792.
Laje, G., Paddock, S., Manji, H., et al. (2007). Genetic markers of suicidal ideation emerging during citalopram treatment of major depression. American Journal of Psychiatry, 164, 1530–1538.
Llorca, P. M., Brousse, G., & Schwan, R. (2005). Escitalopram for treatment of major depressive disorder in adults. Encephale, 31, 490–501.
Nelson, J. C., Delucchi, K., & Schneider, L. (2007). Suicidal thinking and behavior during treatment with sertraline in late-life depression. American Journal of Geriatric Psychiatry, 15(7), 573–580.
Nemeroff, C. B., Kalali, A., & Keller, M. (2007). Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry, 64(4), 466–472.
Nemeroff, C. B., Entsvah, R., & Benattia, I., et al. (2008). Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs. Biological Psychiatry, 63(4), 424–434.
Schneeweiss, S., Patrick, A. R., Solomon, D. H., et al. (2010). Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years’ data. Archives of General Psychiatry, 67(5), 497–506.
Teicher, M. H., Glod, C., & Cole, J. O. (1990). Emergence of intense suicidal preoccupation during fluoxetine treatment. American Journal of Psychiatry, 147(2), 207–210.
Thase, M. E. (1998). Effects of venlafaxine on blood pressure: a meta-analysis of original data from 3744 depressed patients. Journal of Clinical Psychiatry, 59, 502–508.
Tiihonen, J., Lonnqvist, J., Haukka, J., et al. (2006). Antidepressants and the risk of suicide, attempted suicide, and overall mortality in a nationwide cohort. Archives of General Psychiatry, 63, 1358–1367.
US Food and Drug Administration: Clinical Review: relationship between antidepressant drugs and suicidality in adults. Available from: http://www.fda.gov/ohrms/dockets/ac/06/briefing/2006–4272b1–01-FDA.pdf)
Valenstein, M., Kim, H. M., Ganoczy, D., et al. (2012). Antidepressant agents and suicide death among US Department of Veterans Affairs patients in depression treatment. Journal of Clinical Psychopharmacology, 32(2), 346–353.
Vanderburg, D. G., Batzer, E., Fogel, I., et al (2009). A pooled analysis of suicidality in double-blind, placebo-controlled studies of sertraline in adults. Journal of Clinical Psychiatry, 70(5), 674–683.
Vey, E. L., & Kovelman, I. (2010). Adverse events, toxicology and post-mortem data on duloxetine: case reports and literature survey. Journal of Forensic and Legal Medicine, 17(4), 175–185.
von Knorring, A. L., Olsson, G. I., Thomsen, P. H., et al. (2006). A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder. Journal of Clinical Psychopharmacology, 26(3), 311–315.

References

Allen, M. H., Abar, B. W., McCormick, M., et al. (2013). Screening for suicidal ideation and attempts among emergency department medical patients: instrument and results from the Psychiatric Emergency Research Collaboration. Suicide and Life-Threatening Behavior, 43(3), 313–323.
Appelbaum, P. S. (2007). Assessment of patients’ competence to consent to treatment. New England Journal of Medicine, 357, 1834–1840.
Baca-Garcia, E., Parra, C. P., Perez-Rodriguez, M. M., et al. (2007). Psychosocial stressors may be strongly associated with suicide attempts. Stress and Health, 23, 191–198.
Baraff, L. J., Janowicz, N. & Asarnow, J. R. (2006). Survey of California emergency departments about practices for management of suicidal patients and resources available for their care. Annals of Emergency Medicine, 48, 452–458.
Betz, M. E., Sullivan, A. F., Manton, A. P., et al. (2013). Knowledge, attitudes, and practices of emergency department providers in the care of suicidal patients. Depression and Anxiety. Epub Feb 20, 2013.
Bilén, K., Ponzer, S., Ottosson, C., Castrén, M., & Pettersson, H. (2013). Deliberate self-harm patients in the emergency department: who will repeat and who will not? Validation and development of clinical decision rules. Emergency Medicine Journal, 30(8), 650–656.
Boltan, I. M., Spiwak, R. & Sareen, J. (2012). Predicting suicide attempts with the SAD PERSONS scale: a longitudinal analysis. Journal of Clinical Psychiatry, 73(6), e735–741.
Bryan, C. J., & Rudd, M. D. (2006). Advances in the assessment of suicide risk. Journal of Clinical Psychology, 62, 185–200.
Cooper, J., Kapur, N., Dunning, J., et al. (2006). A clinical tool for assessing risk after self-harm. Annals of Emergency Medicine, 48, 459–466.
Department of Veterans Affairs. (2010). Memorandum re: Standardized Suicide Nomenclature (Self-Directed Violence Classification System). Washington, DC: US Government Printing Office.
Hazelton, L. D., Sterns, G. L., & Chisholm, T. (2003). Decision-making capacity and alcohol abuse: clinical and ethical considerations in personal care choices. General Hospital Psychiatry, 25, 130–135.
Hockberger, R. S., & Rothstein, R. J. (1988). Assessment of suicide potential by nonpsychiatrists using the SAD PERSONS score. The Journal of Emergency Medicine, 6, 99–107.
Jacobs, D., & Brewer, M. (2004). APA practice guideline. Psychiatric Annals, 34, 373.
Joiner, Jr, T. E., Walker, R. L., Rudd, M. D. & Jobes, D. A. (1999). Scientizing and routinizing the assessment of suicidality in outpatient practice. Professional Psychology: Research and Practice, 30, 447–453.
Joint Commission. (2011). Hospital National Patient Safety Goals, 2011 (accessed 3/20/2014) http://www.jointcommission.org/assests/1/6/2011_NPSGs_HAP.pdf.
Kapur, N., Cooper, J., King-Hele, S., et al. (2006). The repetition of suicidal behavior: a multicenter cohort study. Journal of Clinical Psychiatry, 67, 1599–1609.
Lukens, T. W., Wolf, S. J. J., Edlow, J. A., et al. (2006). Clinical policy: Critical issues in the diagnosis and management of the adult psychiatric patient in the emergency department. Annals of Emergency Medicine, 47(1), 79–99.
Melonas, J. M. (2011). Patients at risk for suicide: risk management and patient safety considerations to protect the patient and the physician. Innovations in Clinical Neuroscience, 8, 45.
Mitchell, A., & Dennis, M. (2006). Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff. Emergency Medicine Journal, 23, 251–255.
O’Carroll, P. W., Berman, A. L., Maris, R. W., et al. (1996). Beyond the Tower of Babel: a nomenclature for suicidology. Suicide and Life-Threatening Behavior, 26, 237–252.
Ronquillo, L., Minassian, A., Vilke, G. M. & Wilson, M. P. (2012). Literature-based recommendations for suicide assessment in the emergency department: a review. The Journal of Emergency Medicine, 43(5), 836–842.
Simon, R. I. (2003). Clinical Psychiatry and the Law. Washington DC: American Psychiatric Publishing.
Simpson, S., & Stacy, M. (2004). Avoiding the malpractice snare: documenting suicide risk assessment. Journal of Psychiatric Practice, 10, 185–189.
Stanley, B., & Brown, G. K. (2012). Safety planning intervention: a brief intervention to mitigate suicide risk. Cognitive and Behavioral Practice, 19, 256–264.
Ting, S. A., Sullivan, A. F., Boudreaux, E. D., Miller, I., & Camargo, C. A. (2012). Trends in US emergency department visits for attempted suicide andself-inflicted injury, 1993–2008. General Hospital Psychiatry, 34, 557–565.
Zinkler, M., & Priebe, S. (2002). Detention of the mentally ill in Europe: a review. Acta Psychiatrica Scandinavica, 106, 3–8.

References

Allard, R., Marshall, M., & Plante, M. C. (1992). Intensive follow-up does not decrease the risk of repeat suicide attempts. Suicide and Life-Threatening Behavior, 22, 303–314.
Asarnow, J. R., Jaycox, L. H., Duan, N., et al. (2005). Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics. JAMA: the Journal of the American Medical Association, 293, 311–319.
Asarnow, J. R., Baraff, L. J., Berk, M., et al. (2011). An emergency department intervention for linking pediatric suicidal patients to follow-up mental health treatment. Psychiatric Services, 62, 1303–1309.
Bateman, A., & Fonagy, P. (1999). Effectiveness of partial hospitalization in the treatment of borderline personality disorder: a randomized controlled trial. American Journal of Psychiatry, 156, 1563–1569.
Bateman, A., & Fonagy, P. (2001). Treatment of borderline personality disorder with psychoanalytically oriented partial hospitalization: an 18-month follow-up. American Journal of Psychiatry, 158, 36–42.
Beautrais, A. L., Gibb, S. J., Faulkner, A., et al. (2010). Postcard intervention for repeat self-harm: Randomized controlled trail. The British Journal of Psychiatry, 197, 55–60.
Bennewith, O., Stocks, N., Gunnell, D., et al. (2002). General practice based intervention to prevent repeat episodes of deliberate self harm: cluster randomised controlled trial. BMJ: British Medical Journal, 324, 1254–1257.
Bertolote, J. M., Fleischmann, A., De Leo, D., et al. (2010). Repetition of suicide attempts: Data from emergency care settings in five culturally different low- and middle-income countries participating in the WHO SUPRE-MISS study. Crisis, 31, 194–201.
Brent, D. A., Holder, D., Kolko, D., et al. (1997). A clinical psychotherapy trial for adolescent depression comparing cognitive, family, and supportive therapy. Archives of General Psychiatry, 54, 877–885.
Britton, P. C., Patrick, H., Wenzel, A., et al. (2011). Integrating motivational interviewing and self-determination theory with cognitive behavioral therapy to prevent suicide. Cognitive and Behavioral Practice, 18, 16–27.
Brown, G. K., Beck, A. T., Steer, R. A., et al. (2000). Risk factors for suicide in psychiatric outpatients: a 20-year prospective study. Journal of Consulting and Clinical Psychology, 68, 371–377.
Brown, G. K., Ten Have, T., Henriques, G. R., et al. (2005). Cognitive therapy for the prevention of suicide attempts. JAMA: the Journal of the American Medical Association, 294, 563–570.
Butler, A. C., Chapman, J. E., Forman, E. M., et al. (2006). The empirical status of cognitive-behavioral therapy: a review of meta-analyses. Clinical Psychology Review, 26, 17–31.
Carr, A. (2012). Family Therapy: Concepts, Process and Practice. Hoboken: Wiley-Blackwell.
Carter, G. L., Clover, K., Whyte, I. M., et al. (2005). Postcards from the EDge project: randomised controlled trial of an intervention using postcards to reduce repetition of hospital-treated deliberate self-poisoning. BMJ: British Medical Journal, 331, 805–807.
Carter, G., Clover, K., Whyte, I., et al. (2007). Postcards from the EDge project: 24-month outcomes of a randomized controlled trial for hospital-treated self-poisoning. The British Journal of Psychiatry, 191, 548–553.
Cedereke, M., Monti, K., & Ojenhagen, A. (2002). Telephone contact with patients in the year after a suicide attempt: Does it affect treatment attendance and outcome? A randomized controlled study. European Psychiatry, 17, 82–91.
Centers for Disease Control and Prevention. (2012). Suicide Facts at a Glance. Available at: http://www.cdc.gov/ViolencePrevention/pdf/Suicide_DataSheet-a.pdf (Accessed 1 February 2013).
Chanen, A. M., Jackson, H. J., McCutcheon, L. K., et al. (2008). Early intervention for adolescents with borderline personality disorder using cognitive analytic therapy: randomised controlled trial. British Journal of Psychiatry, 6, 477–484.
Chowdhury, N., Hicks, R. C., & Kreitman, N. (1973). Evaluation of an after-care service for parasuicide (attempted suicide) patients. Social Psychiatry and Psychiatric Epidemiology, 8, 67–81.
Conner, K. R., Britton, P. C., Sworts, L. M., et al. (2007). Suicide attempts among individuals with opiate dependence: The critical role of belonging. Addictive Behaviors, 7, 1395–1404.
Cotgrove, A., Zirinsky, L., Black, D., et al. (1995). Secondary prevention of attempted suicide in adolescence. Journal of Adolescence, 18, 569–577.
Deisenhammer, E. A., Huber, M., Kemmler, G., et al. (2007). Psychiatric hospitalizations during the last 12 months before suicide. General Hospital Psychiatry, 29, 63–65.
Desai, R. A., Dausey, D. J., & Rosenheck, R. A. (2005). Mental health service delivery and suicide risk: the role of individual patient and facility factors. American Journal of Psychiatry, 162, 311–318.
Diamond, G. S., Wintersteen, M. B., Brown, G. K., et al. (2010). Attachment-based family therapy for adolescents with suicidal ideation: a randomized controlled trial. Journal of the American Academy of Child & Adolescent Psychiatry, 49, 122–131.
Dixon, W. A., Heppner, P. P., & Rudd, M. D. (1994). Problem solving appraisal, hopelessness, and suicide ideation: Evidence for a mediational model. Journal of Counseling Psychology, 41, 91–98.
Donaldson, D., Spirito, A., & Esposito-Smythers, C. (2005). Treatment for adolescents following a SA: Results of a pilot trial. Journal of the American Academy of Child & Adolescent Psychiatry, 44, 113–120.
Esposito-Smythers, C., Spirito, A., Kahler, C. W., et al. (2011). Treatment of co-occurring substance abuse and suicidality among adolescents: A randomized trial. Journal of Consulting and Clinical Psychology, 79, 728–739.
Fleischmann, A., Bertolote, J. M., Wasserman, D., et al. (2008). Effectiveness of brief intervention and contact for suicide attempters: A randomized control trial in five countries. Bulletin of the World Health Organization, 86, 703–709.
Gibbons, J. S., Butler, J., Urwin, P., et al. (1978). Evaluation of a social work service for self-poisoning patients. The British Journal of Psychiatry, 133, 111–118.
Gray, S. M., & Otto, M. W. (2001). Psychosocial approaches to suicide prevention: applications to patients with bipolar disorder. The Journal of Clinical Psychiatry Supplement, 62, 56–64.
Green, J. M., Wood, A. J., Kerfoot, M. J., et al. (2011). Group therapy for adolescents with repeated self harm: randomised controlled trial with economic evaluation. BMJ: British Medical Journal, 342, 1–12.
Guthrie, E., Kapur, N., Mackway-Jones, K., et al. (2001). Randomised controlled trial of brief psychological intervention after deliberate self poisoning. BMJ: British Medical Journal, 323, 135–138.
Hamza, C. A., Stewart, S. L., & Willoughby, T. (2012). Examining the link between nonsuicidal self-injury and suicidal behavior: A review of the literature and an integrated model. Clinical Psychology Review, 32, 482–495.
Harrington, R., Kerfoot, M., Dyer, E., et al. (1998). Randomized trial of a home-based family intervention for children who have deliberately poisoned themselves. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 512–518.
Hassanian-Moghaddam, H., Saeedeh, S., Kolahi, A., et al. (2011). Postcards in Persia: Randomised controlled trial to reduce suicidal behaviors 12 months after hospital-treated self-poisoning. British Journal of Psychiatry, 198, 309–316.
Hassanzadeh, M., Khajeddin, N., Nojomi, M., et al. (2010). Brief intervention and contact after deliberate self-harm: An Iranian randomized controlled trial. Iranian Journal of Psychiatry and Behavioral Sciences, 4, 5–12.
Hastings, M., Northman, L., & Tangney, J. (2002). Shame, guilt, and suicide. In T. Joiner & M. D. Rudd (Eds.) Suicide Science, 67–79.
Hatcher, S., Sharon, C., Parag, V., et al. (2011). Problem solving therapy for people who present to hospital with self-harm: Zelen randomised controlled trial. The British Journal of Psychiatry, 199, 310–316.
Hawton, K., Bancroft, J., Catalan, J., et al. (1981). Domiciliary and outpatient treatment of self-poisoning patients by medical and non-medical staff. Psychological Medicine, 11, 169–177.
Hawton, K., McKeown, S., Day, A., et al. (1987). Evaluation of outpatient counselling compared with general practitioner care following overdoses. Psychological Medicine, 17, 751–761.
Hazell, P. L., Martin, G., McGill, K., et al.(2009). Group therapy for repeated deliberate self-harm in adolescents: failure of replication of a randomized trial. Journal of the American Academy of Child & Adolescent Psychiatry, 48, 662–670.
Hirsch, J. K., Webb, J. R., & Jeglic, E. L. (2012). Forgiveness as a moderator of the association between anger expression and suicidal behaviour. Mental Health, Religion & Culture, 15, 279–300.
Ho, T. P. (2006). Duration of hospitalization and post discharge suicide. Suicide and Life-Threatening Behavior, 36, 682–686.
Huey, S. J., Henggeler, S. W., Rowland, M. D., et al. (2004). Multisystemic therapy effects on attempted suicide by youths presenting psychiatric emergencies. Journal of the American Academy of Child & Adolescent Psychiatry, 43, 183–190.
Huprich, S. K. (2004). Psychodynamic conceptualization and treatment of suicidal patients. Journal of Contemporary Psychotherapy, 34, 23–39.
Hvid, M., Vangborg, K., Sørensen, H. J., et al. (2011). Preventing repetition of attempted suicide-II. The Amager Project, a randomized controlled trial. Nordic Journal of Psychiatry, 65, 292–298.
Joiner, T. E. (2005). Why People Die by Suicide. Cambridge: Harvard University Press.
Joiner, T. E., & Rudd, M. D. (1996). Disentangling the interrelations between hopelessness, loneliness, and suicidal ideation. Suicide and Life-Threatening Behavior, 26, 19–26.
Koons, C. R., Robins, C. J., Lindsey Tweed, J., et al. (2001). Efficacy of dialectical behavior therapy in women veterans with borderline personality disorder. Behavior Therapy, 32, 371–390.
Liberman, R. P., & Eckman, T. (1981). Behavior therapy vs insight-oriented therapy for repeated suicide attempters. Archives of General Psychiatry, 38, 1126–1130.
Linehan, M. (1993). Skills Training Manual for Treating Borderline Personality Disorder. New York: Guilford Press.
Linehan, M. M., Armstrong, H. E., Suarez, A., et al. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry, 48, 1060–1064.
Linehan, M. M., Heard, H. L., & Armstrong, H. E. (1993). Naturalistic follow-up of a behavioral treatment for chronically parasuicidal borderline patients. Archives of General Psychiatry, 50, 971–974.
Linehan, M. M., Comtois, K. A., Murray, A. M., et al. (2006). Two-year randomized controlled trial and follow-up of dialectical behavior therapy vs therapy by experts for suicidal behaviors and borderline personality disorder. Archives of General Psychiatry, 63, 757–766.
Malone, K. M., Oquendo, M. A., Haas, G. L., et al. (2000). Protective factors against suicidal acts in major depression: reasons for living. American Journal of Psychiatry, 157, 1084–1088.
McLeavey, B. C., Daly, R. J., Ludgate, J. W., et al. (1994). Interpersonal problem solving skills training in the treatment of self-poisoning patients. Suicide and Life-Threatening Behavior, 24, 382–394.
McMain, S., Links, P., Gnam, W., et al. (2009). A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. American Journal of Psychiatry, 166, 1365–1374.
Möller, H. J. (1989). Efficacy of different strategies of aftercare for patients who have attempted suicide. Journal of the Royal Society of Medicine, 82, 643–647.
Morgan, H. G., Jones, E. M., & Owen, J. H. (1993). Secondary prevention of non-fatal deliberate self-harm. The green card study. The British Journal of Psychiatry, 163, 111–112.
Motto, J. A. (1976). Suicide prevention for high-risk persons who refuse treatment. Suicide and Life-Threatening Behavior, 6, 223–230.
Motto, J. A., & Bostrom, A. G. (2001). A randomized controlled trial of postcrisis suicide prevention. Psychiatric Services, 52, 828–833.
Nock, M. K. (2010). Self-injury. Annual Review of Clinical Psychology, 6, 339–363.
Nordentoft, M., Jeppesen, P., Abel, M., et al. (2002). OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial. The British Journal of Psychiatry, 181, 98–106.
Patsiokas, A. T., & Clum, G. A. (1985). Effects of psychotherapeutic strategies in the treatment of suicide attempters. Psychotherapy: Theory, Research, Practice, Training, 22, 281–290.
Pietrzak, R. H., Russo, A. R., Ling, Q., et al. (2011). Suicidal ideation in treatment-seeking Veterans of Operations Enduring Freedom and Iraqi Freedom: The role of coping strategies, resilience, and social support. Journal of Psychiatric Research, 45, 720.
Pistorello, J., Fruzzetti, A. E., MacLane, C., et al. (2012). Dialectical Behavior Therapy (DBT) applied to college students: a randomized clinical trial. Journal of Consulting and Clinical Psychology, 80, 982–994.
Pompili, M., Innamorati, M., Szanto, K., et al. (2011). Life events as precipitants of suicide attempts among first-time suicide attempters, repeaters, and non-attempters. Psychiatry Research, 186, 300–305.
Qin, P., & Nordentoft, M. (2005). Suicide risk in relation to psychiatric hospitalization: evidence based on longitudinal registers. Archives of General Psychiatry, 62, 427–532.
Raj, A. J., Kumaraiah, V., & Bhide, A. V. (2001). Cognitive-behavioral intervention in deliberate self-harm. Acta Psychiatrica Scandinavica, 104, 340–345.
Rich, C. L., Warsradt, G. M., Nemiroff, R. A., et al. (1991). Suicide, stressors, and the life cycle. The American Journal of Psychiatry, 148, 524–527.
Robinson, J., Yuen, H. P., Gook, S., et al. (2012). Can receipt of a regular postcard reduce suicide-related behaviour in young help seekers? A randomized controlled trial. Early Intervention in Psychiatry, 6, 145–152.
Rudd, M., David, M., Rajab, H., et al. (1994). Problem solving appraisal in suicide ideators and attempters. American Journal of Orthopsychiatry, 64, 136–149.
Rudd, M. D., Rajab, M. H., Orman, D. T., et al. (1996). Effectiveness of an outpatient intervention targeting suicidal young adults: preliminary results. Journal of Consulting and Clinical Psychology, 64, 179–190.
Salkovskis, P. M., Atha, C., & Storer, D. (1990). Cognitive-behavioural problem solving in the treatment of patients who repeatedly attempt suicide. A controlled trial. The British Journal of Psychiatry, 157, 871–876.
Slee, N., Garnefski, N., van der Leeden, R., Arensman, E., et al. (2008). Cognitive–behavioural intervention for self-harm: randomised controlled trial. The British Journal of Psychiatry, 192, 202–211.
Stepp, S. D., Morse, J. Q., Yaggi, K. E., et al. (2011). The role of attachment styles and interpersonal problems in suicide related behaviors. Suicide and Life-Threatening Behavior, 38, 592–607.
Tarrier, N., Haddock, G., Lewis, S., et al. (2006). Suicide behaviour over 18 months in recent onset schizophrenic patients: the effects of CBT. Schizophrenia Research, 83, 15–27.
Tidemalm, D., Långström, N., Lichtenstein, P., et al. (2008). Risk of suicide after suicide attempt according to coexisting psychiatric disorder: Swedish cohort study with long term follow-up. BMJ: British Medical Journal, 337, 2205–2210.
Turner, R. M. (2000). Naturalistic evaluation of dialectical behavior therapy-oriented treatment for borderline personality disorder. Cognitive and Behavioral Practice, 7, 413–419.
Tyrer, P., Thompson, S., Schmidt, U., et al. (2003). Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychological Medicine, 33, 969–976.
Vaiva, G., Ducrocq, F., Meyer, P., et al. (2006). Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ: British Medical Journal, 332, 1241–1245.
van den Bosch, L. M., Koeter, M. W., Stijen, T., et al. (2005). Sustained efficacy of dialectical behaviour therapy for borderline personality disorder. Behaviour Research and Therapy, 43, 1231–1241.
van der Sande, R., van Rooijen, L., Buskens, et al. (1997). Intensive inpatient and community intervention versus routine care after attempted suicide. A randomised controlled intervention study. The British Journal of Psychiatry, 171, 35–41.
van Heeringen, C., Jannes, S., Buylaert, W., et al. (1995). Management of non-compliance with referral to outpatient after-care among attempted suicide patients: A controlled intervention study. Psychological Medicine, 25, 963–970.
Van Orden, K. A., Witte, T. K., Cukrowicz, K. C., et al. (2010). The interpersonal theory of suicide. Psychological Review, 117, 575–600.
Verheul, R., van den bosch, L. M., Koeter, M. W., et al. (2003). Dialectical behaviour therapy for women with borderline personality disorder 12-month, randomised clinical trial in The Netherlands. The British Journal of Psychiatry, 182, 135–140.
Waterhouse, J., & Platt, S. (1990). General hospital admission in the management of parasuicide: A randomised controlled trial. The British Journal of Psychiatry, 156, 236–242.
Weinberg, I., Gunderson, J. G., Hennen, J., et al. (2006). Manual assisted cognitive treatment for deliberate self-harm in borderline personality disorder patients. Journal of Personality Disorders, 20, 482–492.
Weissman, M. M. (2010). Interpersonal psychotherapy. In Corsini Encyclopedia of Psychology. Hoboken: Wiley-Blackwell.
Welu, T. C. (1977). A follow-up program for suicide attempters: Evaluation of effectiveness. Suicide and Life-Threatening Behavior, 7, 17–30.
Wenzel, A., & Beck, A. T. (2008). A cognitive model of suicidal behaviors: Theory and treatment. Applied and Preventive Psychology, 12, 189–201.
Wood, A., Trainor, G., Rothwell, J., et al. (2001). Randomized trial of group therapy for repeated deliberate self-harm in adolescents. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1246–1253.
World Health Organization. (1996). Prevention of Suicide: Guidelines for the Formulation and Implementation of National Strategies. Geneva, Switzerland.
Wright, J. H. (2006). Cognitive behavior therapy: Basic principles and recent advances. Focus, 4, 173–178.
Yim, P., Yip, P. S. F., Li, R., et al. (2004). Suicide after discharge from psychiatric inpatient care: a case-control study in Hong Kong. Australian & New Zealand Journal of Psychiatry, 38, 65–72.